Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058

Sehatpour, P., Javitt, D. C., De Baun, H. M., Carlson, M., Beloborodova, A., Margolin, D. H., Carlton, M. B. L., Brice, N. L., & Kantrowitz, J. T. (2021). Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058. Neuropsychopharmacology, 47(3), 711–718. https://doi.org/10.1038/s41386-021-01170-8
Authors:
Pejman Sehatpour
Daniel C. Javitt
Heloise M. De Baun
Marlene Carlson
Anna Beloborodova
David H. Margolin
Mark B. L. Carlton
Nicola L. Brice
Joshua T. Kantrowitz
Affiliated Authors:
Pejman Sehatpour
Daniel C. Javitt
Heloise M. De Baun
Marlene Carlson
Anna Beloborodova
Joshua T. Kantrowitz
Columbia Affiliation:
elink
Publication Type:
Article
Unique ID:
10.1038/s41386-021-01170-8
PMID:
34667294
DOI:
10.1038/s41386-021-01170-8
Journal:
Neuropsychopharmacology
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record

Record Created: